Corporate Updates

Japan-based M3 acquires majority stakes in Neuroglia Health

Views: 835
M3 acquires stake

Japanese health-tech firm M3 has acquired a majority stakes in Neuroglia Health Private Limited (NHPL), a Bengaluru-based startup which provides web-based applications to medical professionals including doctors and medical students.

The amount of the acquisition has not been revealed from either side. NHPL also owns and operates an app DailyRounds.

Last year M3 launched an online platform Health Impetus Private Ltd. (HIPL), which enables doctors to keep abreast with the latest information of healthcare sector i.e research, medical news, and evidence-based medicine.

Also read: Affordable World Class Medical Services Needed: Dr Ashok Seth

Responding to the development, Dr Deepu Sebin, chief executive of Neuroglia Health, said: “We are very excited with this development. With the support of M3 we will be offer better services to the existing doctors. Further, we hope to bring in new doctors as well. The goal is to be largest doctor network in India, not just by registered numbers, but in terms of active users as well.”

Shedding light on how the acquisition will help in long run, Amit Singh, CEO of HIPL (M3 India), said: “The acquisition will enable M3 India to escalate its marketing support and market research businesses to pharmaceutical and medical devices companies through expansion of doctor membership and enhancement of medical education contents.”

Latest News

To Top